Feeds › Patents
Patents
New US patents granted to public companies.
About this data
- What it is
- The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
- Who files it
- The USPTO publishes each grant.
- How current
- Grants are published every Tuesday, and we collect them weekly.
- Worth knowing
- A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Patents granted per week, last 12 weeks
Latest patent grants
Showing: ticker EDIT
| Granted | Patent | Owner | Type | Source |
|---|---|---|---|---|
| Oct 13, 2026 | 12760330 Compositions and methods for treating CEP290 associated disease | EDIT Editas Medicine, Inc. | utility | Google Patents ↗ |
| Aug 4, 2026 | 12698489 Methods, compositions and components for CRISPR-Cas9 editing of TGFBR… | EDIT Editas Medicine, Inc. | utility | Google Patents ↗ |
| Feb 10, 2026 | 12545912 CRISPR/Cas-related methods and compositions for treating usher syndro… | EDIT Editas Medicine, Inc. | utility | Google Patents ↗ |
| Nov 4, 2025 | 12460231 Crispr/CAS-related methods and compositions for treating primary open… | EDIT Editas Medicine, Inc. | utility | Google Patents ↗ |
| Jul 15, 2025 | 12359223 Systems and methods for modulating chromosomal rearrangements | EDIT Editas Medicine, Inc. | utility | Google Patents ↗ |
| Jun 24, 2025 | 12338436 Synthetic guide molecules, compositions and methods relating thereto | EDIT Editas Medicine, Inc. | utility | Google Patents ↗ |
| Jun 17, 2025 | 12331328 CRISPR/Cas9-mediated exon-skipping approach for USH2A-associated ushe… | EDIT Editas Medicine, Inc. | utility | Google Patents ↗ |
| Jun 10, 2025 | 12325854 Crispr-CPF1-related methods, compositions and components for cancer i… | EDIT Editas Medicine, Inc. | utility | Google Patents ↗ |
| May 13, 2025 | 12297466 Engineered Cas9 nucleases | EDIT Editas Medicine, Inc. | utility | Google Patents ↗ |
| Apr 29, 2025 | 12286727 Assessing nuclease cleavage | EDIT Editas Medicine, Inc. | utility | Google Patents ↗ |
| Apr 1, 2025 | 12264331 Systems and methods for one-shot guide RNA (ogRNA) targeting of endog… | EDIT Editas Medicine, Inc. | utility | Google Patents ↗ |
| Feb 25, 2025 | 12234449 CRISPR/Cas-related methods and compositions for treating Leber's cong… | EDIT Editas Medicine, Inc. | utility | Google Patents ↗ |
| Jan 21, 2025 | 12201699 Compositions and methods for promoting homology directed repair | EDIT Editas Medicine, Inc. | utility | Google Patents ↗ |
13 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:59 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances